Ultralow-intensity NIR light triggered on-demand drug release by employing highly emissive UCNP and photocleavable linker with low bond dissociation energy

Background: The design of novel nanoparticles with higher therapeutic efficacy and lower side effects, is still difficult but encouraging in cancer therapy. Specifically, for upconversion nanoparticles (UCNP)-based drug release, a high intensity of NIR light (1.4~5.0 W/cm(2)) above the maximum permi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Junhui, Zhao, Zhengyan, Liu, Zongjun, Wu, Ruozheng, Wang, You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554517/
https://www.ncbi.nlm.nih.gov/pubmed/31239667
http://dx.doi.org/10.2147/IJN.S201982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554517/
https://www.ncbi.nlm.nih.gov/pubmed/31239667
http://dx.doi.org/10.2147/IJN.S201982

Ejemplares similares